Article info

Download PDFPDF
Review: pioglitazone does not reduce risk of mortality or cardiovascular events in type 2 diabetes

Citation

Review: pioglitazone does not reduce risk of mortality or cardiovascular events in type 2 diabetes

Publication history

  • First published March 30, 2007.
Online issue publication 
March 30, 2007

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.